Instil Bio, Inc. Common Stock
$7.21
$0.03 (+0.42%)
$7.10Day Range$7.40
Key Statistics
Market Cap
$48.90M
Shares Outstanding
6.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 19, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$7.30
Day High
$7.40
Day Low
$7.10
Volume
11.7K
VWAP
$7.20
Prev Close
$7.18
Transactions
--
Acc. Volume
--
About Instil Bio, Inc. Common Stock
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283617 employees3963 MAPLE AVENUE, DALLAS, TX, 75219(972) 499-3350IPO Mar 19, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001789769
- Composite FIGI
- BBG00ZGYN521
- Share Class FIGI
- BBG00ZGYN5X7
- Ticker Root
- TIL
- SIC Code
- 2836
About Instil Bio, Inc. Common Stock (TIL) Stock
Instil Bio, Inc. Common Stock (TIL) closed the 2026-09-17 session at $7.21, up 0.42% versus the previous close (+0.03). The stock opened at $7.30 and traded between $7.10 and $7.40 during that session. Session trading volume was 12K shares. The volume-weighted average price (VWAP) is $7.20.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Instil Bio, Inc. Common Stock has a market capitalization of $48.9 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. TIL is listed on the XNAS exchange. The company employs approximately 17 people. Instil Bio, Inc. Common Stock is headquartered in DALLAS, TX. The recorded listing date is 2021-03-19.
On this page you can find market TIL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.